PAVmed Inc. (PAVM) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

PAVmed Inc.

NASDAQ: PAVM · Real-Time Price · USD
0.48
-0.04 (-7.51%)
At close: Aug 27, 2025, 3:59 PM

PAVmed Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
3M 2.45M 377K 500K
Cost of Revenue
6.04M 6.42M 3.61M 585K
Gross Profit
-3.04M -3.97M -3.24M -85K
Operating Income
-44.49M -68.8M -90.93M -54.39M
Interest Income
254K 505K 169K n/a
Pretax Income
28.43M -79.26M -103.24M -56.13M
Net Income
39.79M -64.17M -88.98M -50.35M
Selling & General & Admin
36.15M 48.53M 60.36M 34.46M
Research & Development
5.93M 14.28M 25.55M 19.85M
Other Expenses
-639K 2.02M 1.78M n/a
Operating Expenses
41.44M 64.83M 87.69M 54.31M
Interest Expense
45K 589K 1.28M n/a
Selling & Marketing Expenses
11.63M 17.58M 19.32M 8.89M
Cost & Expenses
47.48M 71.25M 91.3M 54.89M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
9.67M 7.23M 5.94M 5.17M
Shares Outstanding (Diluted)
9.67M 7.23M 5.94M 5.17M
EPS (Basic)
3.30 -9.16 -15.03 -9.8
EPS (Diluted)
3.30 -9.16 -15.03 -9.8
EBITDA
29.67M -75.74M -99.41M -55.9M
EBIT
28.47M -78.67M -101.96M -56.13M
Depreciation & Amortization
1.2M 2.93M 2.55M 226K